Benchmark Investment Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-617
Closed -$203K 76
2026
Q1
$203K Buy
+617
New +$222K 0.12% 75
2025
Q3
$228K Buy
+616
New +$238K 0.13% 75
2025
Q1
$229K Hold
614
0.15% 84
2024
Q4
$221K Buy
614
+1
+0.2% +$371 0.14% 83
2024
Q3
$222K Hold
613
0.16% 84
2024
Q2
$208K Buy
613
+1
+0.2% +$339 0.15% 86
2024
Q1
$219K Buy
+612
New +$206K 0.17% 86
2022
Q2
Sell
-780
Closed -$209K 103
2022
Q1
$209K Sell
780
-14
-2% -$3.62K 0.16% 140
2021
Q4
$212K Buy
+794
New +$208K 0.17% 95

Other funds holding SYK

Benchmark Investment Advisors's SYK Position: Q2 2026 in Review

Benchmark Investment Advisors sold out of Stryker (SYK) in Q2 2026, closing a stake of 617 shares — an estimated $203K sold.

Benchmark Investment Advisors first reported a position in SYK in Q4 2021 and held it in 9 quarters. The position peaked at $229K in Q1 2025. 2,263 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Benchmark Investment Advisors reported no remaining Stryker position as of Q2 2026 after selling out during the quarter.
  • Benchmark Investment Advisors sold 617 Stryker shares in Q2 2026, an estimated $203K.
  • Benchmark Investment Advisors first reported a position in Stryker in Q4 2021 and held it in 9 quarters.
  • Benchmark Investment Advisors's Stryker position peaked at $229K in Q1 2025.
  • 2,263 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Benchmark Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.